IRCTC Q3 FY26 Results: PAT grows 16% to Rs 394 crore, 175% dividend declared

Nifty IT falls 5.5% as AI concerns hit stocks; Top 10 IT firms lose Rs 1.69 lakh crore in mcap

After 4643% 5-year return, does BSE still offer value for new investors?

Retail inflation rises to 2.75% in January; MoSPI rolls out new CPI series with 2024 base year

India set to get Bangladesh-style zero-duty access in US for cotton-based textile exports: Piyush Goyal

Manufacturing at the core of India’s $35 trillion economy goal by 2047: Govt

Closing Bell: Sensex falls 558 points, Nifty 50 below 25,900 - Anil Singhvi cites reasons for market decline

Bharat Bandh on February 12: Farmers, unions march nationwide; roads blocked, transport hit in several states

PMO leaves South Block after 78 years as PM Modi shifts office to 'Sewa Teerth'

TCS market cap slips below Rs 10 lakh crore for first time since Dec 2020; ICICI Bank overtakes

Glenmark Pharmaceuticals' board is set to meet on Friday, September 26, to consider an interim dividend. The payout, if approved, will be the the company's second such corporate action in the past one year.&nbsp;&nbsp;

Largecap pharma firm's board set to meet on this date to consider first interim dividend in 18 years

Long-Term Stocks to Buy: Domestic brokerages have released fresh stock picks across key sectors, here are 8&nbsp;stock picks you may consider adding to your portfolio.&nbsp;&nbsp;

8 Stocks to Buy for Long Term: Brokerages bullish on Astral, Maruti Suzuki, L&T Finance & 5 others; note down targets

Glenmark Pharma Share Price News: Glenmark Pharma shares are facing selling pressure on Dalal Street after the drug maker reported a weaker-than-expected set of results for the quarter ended June 30 (Q1 FY26).&nbsp;

Glenmark Pharma shares tumble despite market-wide rally post-Q1 results

Stocks to Buy: From cement and beverages to power and pharma, brokerages are betting big on select Indian companies. With strong execution, expansion plans, and healthy financials, here are 10 stocks that have recently earned a 'Buy' rating from top brokerages.

<div>&nbsp;</div>

Stocks to Buy: Analysts recommend NTPC, Varun Beverages, FirstCry, Glenmark & more—Check out targets

Zee Business editor, Anil&nbsp;Singhvi&nbsp;breaks down implications for Indian pharma and highlights key stocks&nbsp;to watch 
&nbsp;

Trump’s pharma order spooks Indian drug makers; Anil Singhvi expects one stock to lead rebound

Glenmark Pharmaceuticals has launched injection Acetylcysteine in the US after acquiring its abbreviated new drug application (ANDA) from Aspen Pharma USA. According to SBI Securities, the development is a long-term positive for the Indian drug maker.

Glenmark Pharma launches Acetylcysteine injection in US; long-term positive? 

The revenue from operations at Glenmark Pharma during Q3FY25&nbsp;also marked a 35.1 per cent year-on-year (YoY) rise to Rs&nbsp;3,387.6 crore, coming in higher-than-estimates of Rs 3,350 crore.

Glenmark Pharmaceuticals gains up to 6% on return to profitability in Q3

Which stocks will be in focus today including Glenmark Pharma, Ola Electric, Welspun Living and Hindustan Zinc? On the basis of which news will there be action in the market? What are the important triggers for the market? Know here in Stock In News.

Which stocks will be in focus today including Glenmark Pharma, Ola Electric, Welspun Living and Hindustan Zinc? 

Glenmark's Topiramate capsules USP, 15 mg and 25 mg have been determined by the FDA to be bioequivalent and therapeutically equivalent to Topamax capsules, 15 mg and 25 mg of Janssen&nbsp;Pharmaceuticals, Inc., and will be distributed in the US by Glenmark Pharmaceuticals Inc., USA, it added.

Glenmark Pharma share price pharmaceuticals firm gets usda nod for seizure treatment drug Topiramate capsules 

Results Review : Divi's Laboratories, Torrent Pharma, Aurobindo Pharma, Glenmark Pharma, United Spirits, Hindalco, Ashok Leyland और NTPC के नतीजे कैसे रहे? नतीजों के बाद किन शेयरों में करें खरीदारी? जानिए एनालिसिस Anil Singhvi से.
 

Post-Results Analysis: Which Stocks to Buy? Insights by Anil Singhvi

Glenmark Pharma news:&nbsp;Glenmark Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic brimonidine tartrate and timolol maleate ophthalmic solution indicated in the treatment increased pressure in the eye caused by glaucoma or other conditions.

Glenmark gets USFDA nod for generic ophthalmic solution

Glenmark Pharma Share Price Today NSE, BSE:&nbsp;Shares of Glenmark Pharma, which has a market cap of Rs 16,296, have given a mulitbagger return of 148 per cent in in two years.&nbsp;

Glenmark Pharma shares hit 52-week high as company gets USFDA nod for generic anti-inflammatory drug

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.

Lupin, Glenmark recall drugs in US market: USFDA

Pharma stocks today NSE BSE:&nbsp;As of 10:54 a.m., Nifty Pharma, which is an indicator of healthcare and pharma stocks' performance, was down 0.67 per cent at 18,829.35 levels.

Pharma stocks slip after government bans companies from offering gifts to healthcare professionals

Glenmark Pharma jumped 7% in 5 days... Will Glenmark Pharma break the high of 52 weeks? What is the reason for the rise in this pharma stock?

Glenmark Pharma's Skyrocketing Journey: 7% Surge in 5 Days Revealed!

Why the rise in Glenmark Pharma? What is special about Glenmark Pharma's Concol?

Exploring Glenmark Pharma: What's Driving the Rapid Growth? | Zee Business

Glenmark Pharma stock recovers after posting Rs 330.8 crore net loss in Q3. Sales dip due to one-time India impact, forex loss, inflation. Revenue excluding one-time impact up 9% YoY. Gross margins down 750 bps YoY to 58.8%.

Glenmark Pharma Shares Rebound After Q3 Loss, Up 6% | Stock Market News

Glenmark Pharma trades higher despite pharma firm reports loss in December quarter

Glenmark Pharma news:&nbsp;With the execution of this agreement, Ichnos has successfully licensed its two assets for inflammatory and immunological diseases, a key milestone in the company's prioritisation of its pipeline of oncology drug candidates, Ichnos Sciences said in a statement filed on BSE by Glenmark.

Glenmark arm inks licensing pact with Astria Therapeutics

Glenmark Life's board on Monday declared an interim dividend for the financial year 2023-24 of Rs. 22.50/- per equity of the share face value of Rs. 2 each.

Glenmark Life shares jump after pharma firm announces interim dividend

glenmark-pharma

Glenmark Pharmaceuticals' board is set to meet on Friday, September 26, to consider an interim dividend. The payout, if approved, will be the the company's second such corporate action in the past one year.  

Long-Term Stocks to Buy: Domestic brokerages have released fresh stock picks across key sectors, here are 8 stock picks you may consider adding to your portfolio.  

Glenmark Pharma Share Price News: Glenmark Pharma shares are facing selling pressure on Dalal Street after the drug maker reported a weaker-than-expected set of results for the quarter ended June 30 (Q1 FY26). 


Stocks to Buy: From cement and beverages to power and pharma, brokerages are betting big on select Indian companies. With strong execution, expansion plans, and healthy financials, here are 10 stocks that have recently earned a 'Buy' rating from top brokerages.
 

Zee Business editor, Anil Singhvi breaks down implications for Indian pharma and highlights key stocks to watch
 

Zee Business

Home

Personal Finance

India

Economy

Tech

Auto

Markets

Jobs

Indian Railways

World

Videos

Photos

Glenmark Pharma News- Zee Business provides latest news on Glenmark Pharma, Glenmark Pharma news Today, Top News on Glenmark Pharma, update on Glenmark Pharma Stay updated with business news, breaking news headlines.

Glenmark Pharma Latest News- Top News on Glenmark Pharma, Update on Glenmark Pharma, Glenmark Pharma News Today, Breaking News Headlines, Business News | Zee Business

Glenmark Pharma

Largecap pharma firm's board set to meet on this date to consider first interim dividend in 18 years

8 Stocks to Buy for Long Term: Brokerages bullish on Astral, Maruti Suzuki, L&T Finance & 5 others; note down targets

Glenmark Pharma shares tumble despite market-wide rally post-Q1 results

Stocks to Buy: Analysts recommend NTPC, Varun Beverages, FirstCry, Glenmark & more—Check out targets

Trump’s pharma order spooks Indian drug makers; Anil Singhvi expects one stock to lead rebound

Glenmark Pharma launches Acetylcysteine injection in US; long-term positive?

RECOMMENDED

IRCTC Q3 FY26 Results: PAT grows 16% to Rs 394 crore, 175% dividend declared

Nifty IT falls 5.5% as AI concerns hit stocks; Top 10 IT firms lose Rs 1.69 lakh crore in mcap

After 4643% 5-year return, does BSE still offer value for new investors?

Retail inflation rises to 2.75% in January; MoSPI rolls out new CPI series with 2024 base year

India set to get Bangladesh-style zero-duty access in US for cotton-based textile exports: Piyush Goyal

Manufacturing at the core of India’s $35 trillion economy goal by 2047: Govt

Closing Bell: Sensex falls 558 points, Nifty 50 below 25,900 - Anil Singhvi cites reasons for market decline

Bharat Bandh on February 12: Farmers, unions march nationwide; roads blocked, transport hit in several states

PMO leaves South Block after 78 years as PM Modi shifts office to 'Sewa Teerth'

TCS market cap slips below Rs 10 lakh crore for first time since Dec 2020; ICICI Bank overtakes

Glenmark Pharmaceuticals gains up to 6% on return to profitability in Q3

Which stocks will be in focus today including Glenmark Pharma, Ola Electric, Welspun Living and Hindustan Zinc?

Glenmark Pharma share price pharmaceuticals firm gets usda nod for seizure treatment drug Topiramate capsules

Post-Results Analysis: Which Stocks to Buy? Insights by Anil Singhvi

Glenmark gets USFDA nod for generic ophthalmic solution

Glenmark Pharma shares hit 52-week high as company gets USFDA nod for generic anti-inflammatory drug

Lupin, Glenmark recall drugs in US market: USFDA

Pharma stocks slip after government bans companies from offering gifts to healthcare professionals

Glenmark Pharma's Skyrocketing Journey: 7% Surge in 5 Days Revealed!

Exploring Glenmark Pharma: What's Driving the Rapid Growth? | Zee Business

Glenmark Pharma Shares Rebound After Q3 Loss, Up 6% | Stock Market News

Glenmark Pharma trades higher despite pharma firm reports loss in December quarter

Glenmark arm inks licensing pact with Astria Therapeutics

Glenmark Life shares jump after pharma firm announces interim dividend

Top News

IRCTC Q3 FY26 Results: PAT grows 16% to Rs 394 crore, 175% dividend declared

Nifty IT falls 5.5% as AI concerns hit stocks; Top 10 IT firms lose Rs 1.69 lakh crore in mcap

After 4643% 5-year return, does BSE still offer value for new investors?

Retail inflation rises to 2.75% in January; MoSPI rolls out new CPI series with 2024 base year

India set to get Bangladesh-style zero-duty access in US for cotton-based textile exports: Piyush Goyal

Manufacturing at the core of India’s $35 trillion economy goal by 2047: Govt